191 related articles for article (PubMed ID: 21448305)
1. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
2. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.
Parlak M; Güdücüoğlu H; Bayram Y; Çıkman A; Aypak C; Kılıç S; Berktaş M
Int J Med Sci; 2013; 10(10):1406-11. PubMed ID: 23983603
[TBL] [Abstract][Full Text] [Related]
3. Tigecycline: its potential for treatment of brucellosis.
Dizbay M; Kilic S; Hizel K; Arman D
Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.
Ozhak-Baysan B; Ongut G; Ogunc D; Gunseren F; Sepin-Ozen N; Ozturk F; Aktepe OC; Gultekin M
Pol J Microbiol; 2010; 59(1):55-60. PubMed ID: 20568531
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
9. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
12. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
[No Abstract] [Full Text] [Related]
14. The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media.
Tanyel E; Coban AY; Fisgin NT; Tulek N
Indian J Med Microbiol; 2010; 28(4):370-1. PubMed ID: 20966572
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
[TBL] [Abstract][Full Text] [Related]
16. Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.
Gültekin E; Uyanık MH; Albayrak A; Kılıç S
Eur J Med Res; 2021 Jun; 26(1):57. PubMed ID: 34134763
[TBL] [Abstract][Full Text] [Related]
17. Determining in vitro synergistic activities of tigecycline with several other antibiotics against Brucella melitensis using checkerboard and time-kill assays.
Aliskan H; Can F; Demirbilek M; Colakoglu S; Kilic S; Arslan H
J Chemother; 2009 Feb; 21(1):24-30. PubMed ID: 19297268
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
Sayan M; Kılıc S; Uyanık MH
J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
[TBL] [Abstract][Full Text] [Related]
19. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Ilhan Z; Solmaz H; Ekin IH
J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
